1. National Institutes of Health (NIH). MedlinePlus® website. Glaucoma.
http://www.nlm.nih.gov/medlineplus/glaucoma.html. Accessed November 8, 2013.

2. Mayo Clinic website. Glaucoma. http://www.mayoclinic.com/health/glaucoma/DS00283. Accessed November 8, 2013.

3. Facts about glaucoma. National Eye Institute website. http://www.nei.nih.gov/health/glaucoma/glaucoma_facts.asp. Accessed April 14, 2017.

4. Balwantray CC, Mikelberg FS, Balaszi G, for the Canadian Glaucoma Study Group. Arch Ophthalmol. 2008;126(8):1030-1036.

5. De Moraes CG, Juthani VJ, Liebmann JM, et al. Arch Ophthalmol. 2011;129(5):562-568.

6. AGIS Investigators. Am J Ophthalmol. 2000;130(4):429-440.

7. WebMD®. Glaucoma and your eyes. WebMD® website.
http://www.webmd.com/eye-health/glaucoma-eyes. Accessed November 8, 2013.

8. Are you at risk for glaucoma? Glaucoma Research Foundation website. www.glaucoma.org/glaucoma/are-you-at-risk-for-glaucoma.php. Reviewed January 13, 2011. Accessed April 14, 2017.

9. U.S. National Library of Medicine. PubMed Health website. Fact sheet: glaucoma. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0048141/. Accessed November 8, 2013.

10. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; for Early Manifest Glaucoma Trial Group. Arch Ophthalmol. 2002;120(10):1268-1279.

11. Kass MA, Heuer DK, Higginbotham EJ, et al; for Ocular Hypertension Treatment Study Group. Arch Ophthalmol. 2002;120(6):701-713.

12. LUMIGAN® 0.01% Prescribing Information.

13. U.S. Food and Drug Administration website. Drugs@FDA: Drug details: LUMIGAN® 0.01%. FDA website: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm. Accessed November 8, 2013.